Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

NCT ID: NCT06535867Sponsor: Memorial Sloan Kettering Cancer CenterLast updated: 2026-05-22

Summary

Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers. This program is inclusive of long term surveillance to downstage oral cancer in India

Arms & interventions

  • Diagnostic TestmHealth

    The mobile health (mHealth) program will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and knowledge of oral cancer diagnosis among frontline health providers.

Outcome measures

Primary

  • Comparison of mHealth with conventional oral cancer screening

    To compare the efficacy of conventional screening with mHealth in identification of oral potentially malignant disorders (OPMDs) / oral cancer.

    Time frame: Up to 5 years

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: Yes
Inclusion Criteria: Positive for any one or more of the following: * All individuals aged above 18 years positive for habits (smoking and smokeless tobacco, chewing betel leaf, areca nut, paan masala, and/or regular use of alcohol) * Clinical signs/symptoms (non-healing ulcers, white/ red/red \& white patches in the mouth, restriction of mouth opening and swelling of the neck) * All individuals aged above 40 irrespective of habit/oral lesions Exclusion Criteria: * Individuals already diagnosed with oral cancer and undergoing treatment for oral cancer * Under treatment for tuberculosis or suffering from any acute illness/ debilitating systemic disorders

Study locations (1)

Memorial Sloan Kettering Cancer Center (All protocol activites)

New York, New York, 10065

Recruiting
Milind Rajadhyaksha, PhD · Contact
646-608-2364